Dr. Daniel Albo, MD, PhD

Media Releases

Get to know Surgical Oncologist Dr. Daniel Albo, who serves patients in Augusta, Georgia.

Dr. Albo is a reputable surgical oncologist, physician-scientist, medical researcher, and educator. His clinical expertise is on minimally invasive gastrointestinal surgical oncology, with particular emphasis in colorectal malignancies. He has one of the highest utilization rates for laparoscopic surgery in patients with colon and rectal cancer in the United States, resulting in significant outcomes advantages for patients, including less pain, faster and more complete recoveries, and a lower rate of wound complications.

In his current capacity, he serves as the Director of Surgical Oncology Services, the Director of Health Services Research, and the Co-Leader of the Colorectal Cancer Team at the Georgia Cancer Center at Augusta University. In this role, he has been tasked with the development of patient-centric, integrated, and multidisciplinary surgical services for the cancer patient. He oversees all aspects of program development, as well as efficiency and quality metrics design, implementation, and assessment for all surgical oncology services throughout the Georgia Regents Health System.

Pertaining to his educational background, Dr. Albo earned his medical degree from the University of the Republic in Uruguay in 1991. Upon relocating to the United States, he completed his Doctorate degree in Molecular Biology at Drexel University in 1998. This was followed by a residency in general surgery at Drexel University in 2000, and a fellowship in surgical oncology at the University of Texas MD Anderson Cancer Center in 2002. 

Following his fellowship training, he joined the Medical College of Georgia in 2002, where he developed a surgical oncology program and a multidisciplinary MD/PhD program in oncology. He joined the faculty of Baylor College of Medicine in Houston, Texas in 2004. He also served as the Chief of General Surgery for the Michael E. DeBakey VA Medical Center, where he developed surgical oncology and minimally invasive surgical services as well as a Colorectal Cancer Center. He was subsequently named Vice Chairman of the Michael E. DeBakey Department of Surgery of Baylor College of Medicine in 2012. Years later, in 2015, he joined the team at Augusta University, where he currently serves as the Chair of the Department of Surgery at the Medical College of Georgia.

A Fellow of the American College of Surgeons, the doctor is a member of the Association for Academic Surgery, the Society of Surgical Oncology, and the Society of University Surgeons. He is also board-certified in general surgery by the American Board of Surgery, which is an independent, non-profit organization located in Philadelphia, Pennsylvania, founded for the purpose of certifying surgeons who have met a defined standard of education, training, and knowledge.

Among his research interests and contributions, Dr. Albo has focused on translational and health services research in surgical oncology. In the health services research area, he has published outcomes of minimally invasive surgery utilization patterns, as well as barriers and facilitators for the widespread adoption of minimally invasive surgery in colorectal disease. He has also studied the impact of minimally invasive surgery on reducing the cost of care in colorectal surgery. His work has also dealt with issues of health care disparities in surgical oncology, particularly as it affects minorities. In the translational research arena, his work has focused on the mechanisms of tumor invasion and metastases.

Surgical oncology is the branch of surgery applied to oncology. It focuses on the surgical management of tumors, especially cancerous tumors. A surgical oncologist removes the tumor and nearby tissue during surgery. He or she also performs certain types of biopsies to help diagnose cancer.

Throughout his extensive career, Dr. Albo has made over 100 publications in peer-reviewed journals and multiple book chapters. He is a Co-Editor of ‘Operative Techniques in General Surgery’ and the Editor for the ‘Operative Techniques in Colorectal Surgery’ textbooks.

Recommended Articles

• What Does It Mean If Your Nipple Is Inverted?

  What are inverted nipples?Inverted nipples, also called as nipple retraction, nipple inversion, or invaginated nipple, is a condition in which the nipples point inward instead of out. In some women, nipple retraction can be present at birth. In some cases, the condition may develop due to trauma or...

• Alternative Treatments for Bladder Cancer

  Alternative Treatments for Bladder CancerCancer occurs in various stages, and as it moves from one stage to another, it gets worse. Therefore, as the condition progresses, more effective methods of treatment have to be applied. At times, even two treatment methods can be applied together.In...

• How Can Skin Grafting Treat Melanoma?

  What is melanoma?Melanoma is a type of skin cancer that affects the melanocytes or the skin cells that contain the pigment melanin. It is caused when long or repeated exposure to UV radiation damages the DNA of these skin cells and causes them to divide uncontrollably forming a malignant tumor....

• What Is Gastric Cancer: Causes, Symptoms, Diagnosis, and Treatment

  Gastric cancer, also known as stomach cancer, begins when cancer cells form in the inner lining of the stomach. This disease does not show clear signs and symptoms until it enters the later stages. The cancer may spread from the stomach to essential parts like the liver, lungs, bones, and lymph...

• Ovarian Cancer Is Not Only Deadly, But Very Hard to Detect. Women Need to Stay Vigilant

  September is known as Ovarian Cancer Awareness Month. Ovarian cancer is a type of cancer of the cells of the ovaries. It can occur in several different parts of the ovary, including the germ, stromal or epithelial cells. Germ cells are the cells that become eggs, stromal cells make up the substance...

• Pink Chair Project Celebrates Survivors of Breast Cancer

  Breast cancer is the most common type of cancer among American women, with the exception of skin cancers. It is also the second leading cause of death among women, after lung cancer. The American Cancer Society estimates that there are over 3.1 million breast cancer survivors in the United States,...